Impact of CNS treatment on mood in adult survivors of childhood leukemia

A report from the Children's Cancer Group

Dorie A. Glover, Julianne Byrne, James L. Mills, Leslie L. Robison, H. Stacy Nicholson, Anna Meadows, Lonnie K. Zeltzer

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Purpose: This study assessed the relationship between CNS treatment and psychologic mood using the Profile of Moods State (POMS), a standardized measure of affect, among a large sample of young adult survivors of childhood acute lymphoblastic leukemia (ALL; N = 555). Patients and Methods: Survivors of childhood ALL (ages 18 to 33 years at study entry) participated in a structured telephone interview eliciting demographic, health, and behavioral data and the POMS. Treatment data included total dose of CNS irradiation (CRT) and intrathecal methotrexate (MTX) obtained from medical records. Results: Mood disturbance was reported by 24% of survivors. High-dose CRT and MTX predicted disturbance rates modestly and primarily in combination with education variables. Interactions between educational achievement, a history of attendance in special education classes, and sex were better predictors than treatment type or dose. Non-white males, those younger than 12.5 years of age at diagnosis, and those with negative perceptions of current health and cancer's impact on employment were also at greater risk for mood disturbance (P <.01 to .001). Conclusion: Although most survivors are doing well psychologically, a subset of long-term survivors show potentially serious mood disturbance. Mood disturbance seems to be a function of interactions between preexisting individual difference variables (eg, sex, race/ethnicity), treatment factors, and posttreatment educational experiences. Prevention strategies aimed at childhood cancer survivors at greatest risk for mood disturbance may be improved by focus on posttreatment psychosocial and educational supports.

Original languageEnglish (US)
Pages (from-to)4395-4401
Number of pages7
JournalJournal of Clinical Oncology
Volume21
Issue number23
DOIs
StatePublished - Dec 1 2003
Externally publishedYes

Fingerprint

Survivors
Leukemia
Neoplasms
Therapeutics
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Methotrexate
Special Education
Educational Status
Health
Individuality
Medical Records
Young Adult
Demography
Interviews
Education

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Glover, D. A., Byrne, J., Mills, J. L., Robison, L. L., Nicholson, H. S., Meadows, A., & Zeltzer, L. K. (2003). Impact of CNS treatment on mood in adult survivors of childhood leukemia: A report from the Children's Cancer Group. Journal of Clinical Oncology, 21(23), 4395-4401. https://doi.org/10.1200/JCO.2003.04.089

Impact of CNS treatment on mood in adult survivors of childhood leukemia : A report from the Children's Cancer Group. / Glover, Dorie A.; Byrne, Julianne; Mills, James L.; Robison, Leslie L.; Nicholson, H. Stacy; Meadows, Anna; Zeltzer, Lonnie K.

In: Journal of Clinical Oncology, Vol. 21, No. 23, 01.12.2003, p. 4395-4401.

Research output: Contribution to journalArticle

Glover, DA, Byrne, J, Mills, JL, Robison, LL, Nicholson, HS, Meadows, A & Zeltzer, LK 2003, 'Impact of CNS treatment on mood in adult survivors of childhood leukemia: A report from the Children's Cancer Group', Journal of Clinical Oncology, vol. 21, no. 23, pp. 4395-4401. https://doi.org/10.1200/JCO.2003.04.089
Glover, Dorie A. ; Byrne, Julianne ; Mills, James L. ; Robison, Leslie L. ; Nicholson, H. Stacy ; Meadows, Anna ; Zeltzer, Lonnie K. / Impact of CNS treatment on mood in adult survivors of childhood leukemia : A report from the Children's Cancer Group. In: Journal of Clinical Oncology. 2003 ; Vol. 21, No. 23. pp. 4395-4401.
@article{7d97c913b25e4bf99dfb540b3cd41ba5,
title = "Impact of CNS treatment on mood in adult survivors of childhood leukemia: A report from the Children's Cancer Group",
abstract = "Purpose: This study assessed the relationship between CNS treatment and psychologic mood using the Profile of Moods State (POMS), a standardized measure of affect, among a large sample of young adult survivors of childhood acute lymphoblastic leukemia (ALL; N = 555). Patients and Methods: Survivors of childhood ALL (ages 18 to 33 years at study entry) participated in a structured telephone interview eliciting demographic, health, and behavioral data and the POMS. Treatment data included total dose of CNS irradiation (CRT) and intrathecal methotrexate (MTX) obtained from medical records. Results: Mood disturbance was reported by 24{\%} of survivors. High-dose CRT and MTX predicted disturbance rates modestly and primarily in combination with education variables. Interactions between educational achievement, a history of attendance in special education classes, and sex were better predictors than treatment type or dose. Non-white males, those younger than 12.5 years of age at diagnosis, and those with negative perceptions of current health and cancer's impact on employment were also at greater risk for mood disturbance (P <.01 to .001). Conclusion: Although most survivors are doing well psychologically, a subset of long-term survivors show potentially serious mood disturbance. Mood disturbance seems to be a function of interactions between preexisting individual difference variables (eg, sex, race/ethnicity), treatment factors, and posttreatment educational experiences. Prevention strategies aimed at childhood cancer survivors at greatest risk for mood disturbance may be improved by focus on posttreatment psychosocial and educational supports.",
author = "Glover, {Dorie A.} and Julianne Byrne and Mills, {James L.} and Robison, {Leslie L.} and Nicholson, {H. Stacy} and Anna Meadows and Zeltzer, {Lonnie K.}",
year = "2003",
month = "12",
day = "1",
doi = "10.1200/JCO.2003.04.089",
language = "English (US)",
volume = "21",
pages = "4395--4401",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "23",

}

TY - JOUR

T1 - Impact of CNS treatment on mood in adult survivors of childhood leukemia

T2 - A report from the Children's Cancer Group

AU - Glover, Dorie A.

AU - Byrne, Julianne

AU - Mills, James L.

AU - Robison, Leslie L.

AU - Nicholson, H. Stacy

AU - Meadows, Anna

AU - Zeltzer, Lonnie K.

PY - 2003/12/1

Y1 - 2003/12/1

N2 - Purpose: This study assessed the relationship between CNS treatment and psychologic mood using the Profile of Moods State (POMS), a standardized measure of affect, among a large sample of young adult survivors of childhood acute lymphoblastic leukemia (ALL; N = 555). Patients and Methods: Survivors of childhood ALL (ages 18 to 33 years at study entry) participated in a structured telephone interview eliciting demographic, health, and behavioral data and the POMS. Treatment data included total dose of CNS irradiation (CRT) and intrathecal methotrexate (MTX) obtained from medical records. Results: Mood disturbance was reported by 24% of survivors. High-dose CRT and MTX predicted disturbance rates modestly and primarily in combination with education variables. Interactions between educational achievement, a history of attendance in special education classes, and sex were better predictors than treatment type or dose. Non-white males, those younger than 12.5 years of age at diagnosis, and those with negative perceptions of current health and cancer's impact on employment were also at greater risk for mood disturbance (P <.01 to .001). Conclusion: Although most survivors are doing well psychologically, a subset of long-term survivors show potentially serious mood disturbance. Mood disturbance seems to be a function of interactions between preexisting individual difference variables (eg, sex, race/ethnicity), treatment factors, and posttreatment educational experiences. Prevention strategies aimed at childhood cancer survivors at greatest risk for mood disturbance may be improved by focus on posttreatment psychosocial and educational supports.

AB - Purpose: This study assessed the relationship between CNS treatment and psychologic mood using the Profile of Moods State (POMS), a standardized measure of affect, among a large sample of young adult survivors of childhood acute lymphoblastic leukemia (ALL; N = 555). Patients and Methods: Survivors of childhood ALL (ages 18 to 33 years at study entry) participated in a structured telephone interview eliciting demographic, health, and behavioral data and the POMS. Treatment data included total dose of CNS irradiation (CRT) and intrathecal methotrexate (MTX) obtained from medical records. Results: Mood disturbance was reported by 24% of survivors. High-dose CRT and MTX predicted disturbance rates modestly and primarily in combination with education variables. Interactions between educational achievement, a history of attendance in special education classes, and sex were better predictors than treatment type or dose. Non-white males, those younger than 12.5 years of age at diagnosis, and those with negative perceptions of current health and cancer's impact on employment were also at greater risk for mood disturbance (P <.01 to .001). Conclusion: Although most survivors are doing well psychologically, a subset of long-term survivors show potentially serious mood disturbance. Mood disturbance seems to be a function of interactions between preexisting individual difference variables (eg, sex, race/ethnicity), treatment factors, and posttreatment educational experiences. Prevention strategies aimed at childhood cancer survivors at greatest risk for mood disturbance may be improved by focus on posttreatment psychosocial and educational supports.

UR - http://www.scopus.com/inward/record.url?scp=0442276268&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0442276268&partnerID=8YFLogxK

U2 - 10.1200/JCO.2003.04.089

DO - 10.1200/JCO.2003.04.089

M3 - Article

VL - 21

SP - 4395

EP - 4401

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 23

ER -